Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | 4 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 21 Parkinson's papers of 7,896 | 0.59 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 11209
Sealed predictions
- DAP in dopamine neurons, braak+0.00 (p 1.000) → -0.60 (p 0.090)receipt 11216
Swarm cases
receipt 11216: DAP in dopamine neurons, braak
- power
- full sample -0.28 (p 0.258, n 18), 95% CI -0.66 to +0.21. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.26 (p 0.289, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.53 (p 0.025, n 18). not the mix.
- skeptic
- leave-one-out range -0.39 to -0.19, sign flips 0; without severely affected donors -0.28 (p 0.258, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DAP in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts